SecBot SecBot

AWHL

Aspira Women's Health Inc.
OTC· In Vitro & In Vivo Diagnostic Substances· Inc. DE· CIK 0000926617 Biotech & Drug Discovery
$0.1388 −0.03 (−18.35%)
Oct 27 4:00 PM ET · prev $0.1700
1 year
−71.1%
from $0.4800 · Oct 28
30 days
−39.7%
from $0.2300
52-week range
$0.1388–0.6300
at the low
Avg volume 20D
16.0K
Oct 26 spike 113.6K
Short interest
5.4K
+15.8%
Days to cover
1.0
at average volume
Insider net
+$100.0K
1 buyer · 0 sellers · 12 mo
New fund stakes
0
Q4 2025 13F · 0 exits
Filing reports
6
analyzed by SecBot
SecBot read BEARISH 1 report · latest
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/1
Strongest BEARISH CEO Michael Buhle departed Aspira Women's Health on June 17, 2026, with Chairman John Fraser appointed as…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $100.0K at an average $0.4500. No open-market sales. Price is 69% below their cost.

  • InstitutionsMIXED

    Q4 2025: 1 added (0 new), 0 trimmed or exited.

  • Short sellersBUILDING

    Short interest +15.8% to 5.4K shares. 1.0 days to cover.

  • TrendDOWNTREND

    46% below its 50-day average. New closing low $0.1388 on Oct 27.

Who's buying

13F· Q4 2025
0
new positions
0
exits
FundMoveSharesValue
Pacer Advisors, Inc.ADD354,973$1.1M
OSAIC HOLDINGS, INC.NEAR_EXIT800$392.00
Pacer Advisors, Inc.TRIM184,308$502.4K
OSAIC HOLDINGS, INC.DOUBLED67,484$9.5K
GEODE CAPITAL MANAGEMENT, LLCADD131,968$12.4K
UBS Group AGDOUBLED34,196$3.2K
PNC FINANCIAL SERVICES GROUP, INC.ADD25,000$2.4K
NORTHERN TRUST CORPTRIM16,799$1.6K

Quarterly 13F filings are due 45 days after each quarter ends.

Washington

Corporate Lobbying

1 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
$100.0K
bought · 1 insider
$0
sold · 0 insiders
−69.2%
vs their $0.4500 cost
DateInsiderTypeValue
Sep 8, 2026
Strahley John
Chief Financial Officer
AWARD97,417 sh
Jun 16, 2026
Strahley John
Chief Financial Officer
AWARD75,000 sh
Jun 16, 2026
Strahley John
Chief Financial Officer
AWARD70,000 sh
Jun 5, 2026
SCHULER JACK W
10%+ Owner
BUY300,000 sh
Jun 5, 2026
SCHULER JACK W
10%+ Owner
BUY$100.0K
Sep 17, 2025
cohen Jeffrey k
Director
BUY41,667 sh
Sep 17, 2025
Fraser John D
Director
BUY$7.4K
Sep 17, 2025
cohen Jeffrey k
Director
OTHER$5.0K

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
5,393
shares short
+15.8%
vs prior settlement
1.0
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 8, 2026 Insider
Strahley John was granted 97,417 shares
Chief Financial Officer
Jun 22, 2026 SEC
CEO Michael Buhle departed Aspira Women's Health on June 17, 2026, with Chairman John Fraser appointed as Interim CEO…
8-K — Impact 5/10
Jun 16, 2026 Insider
Strahley John was granted 75,000 shares
Chief Financial Officer
Jun 16, 2026 Insider
Strahley John was granted 70,000 shares
Chief Financial Officer
Jun 9, 2026 SEC
Aspira Women's Health raised approximately $1.485 million in a private placement, issuing 3.3M shares of common stock…
8-K — Impact 6/10
May 29, 2026 SEC
Two directors at Aspira Women's Health purchased a total of $32K in shares on the same day at $0.45/share, three days…
CLUSTER — Impact 5/10
Dec 31, 2025 Inst.
Pacer Advisors, Inc. — ADD
354,973 shares ($1.1M)
Sep 30, 2025 Inst.
OSAIC HOLDINGS, INC. — NEAR_EXIT
800 shares ($392.00)

SecBot reports

6 filings · 1 bullish · 2 bearish · 3 neutral
All AWHL filing & press-release reports (6)